Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 169
News
News | 05 August 2021

Alembic gets USFDA nod for Clomipramine Hydrochloride

It had an estimated market size of US $ 32 million as of June 2021

News
News | 05 August 2021

IPCA Labs reports Q1FY22 net at Rs 306.66 Cr

Total income grew in the quarter

News
News | 05 August 2021

Caplin Point Laboratories posts consolidated PAT in Q1FY22 at Rs 70.85 Cr

EPS climbs to Rs 9.25 for the quarter

News
News | 04 August 2021

Dr Reddy’s relaunch Naproxen Sodium Tablets in the US

It is part of the company’s pain/analgesics portfolio of OTC products

News
News | 04 August 2021

Alkem launch two drugs in US

Ibuprofen and Famotidine tablets approved by FDA

News
News | 04 August 2021

NATCO Pharma transfers Lenalidomide ANDA to Arrow

Arrow is the marketing partner in US

News
News | 04 August 2021

Solara Active Pharma Science clocks net profit of Rs 50.13 crore in Q1FY22

Aditya Puri former MD of HDFC bank joins Solara board as chairman

News
News | 03 August 2021

Evexia Lifecare to manufacture API of Isometa

Robust demand for the product across the Middle East, Africa and Latin America

News
News | 03 August 2021

Morepen Laboratories posts Q1FY22 consolidated PAT of Rs. 30.47 Cr

The company posted net profit of Rs.19.36 crores for the period ended June 30, 2020.

News
News | 02 August 2021

Glenmark signs agreement with SaNOtize to manufacture NONS

The Phase III clinical trial for NONS is expected to be completed by Q4 2021.

News
News | 02 August 2021

Ajanta Pharma aims to file 10-12 ANDAs per annum

India business is growing as per projections; whereas US business will bounce back soon.

News
News | 02 August 2021

Granules India earmarks Rs 400 crore as Capex for FY 22

The company has an outlay of Rs 120-140 crore as R & D expense for FY 22

News
News | 02 August 2021

PI Industries acquires API business of Ind Swift Laboratories

Turnover of API division of ISLL stood at Rs 856.58 crore

News
News | 01 August 2021

Ajanta Pharma Q1FY22 consolidated net profit up at Rs. 173.75 Cr

It posted net profit of Rs.147.76 crores for the period ended June 30, 2020.

News
News | 01 August 2021

Unichem Laboratories Q1FY22 consolidated loss at Rs. 11.48 Cr

The company posted net profit of Rs.2.43 crores for the period ended June 30, 2020.

News
News | 31 July 2021

Zydus Cadila receives approval from USFDA for Fulvestrant Injection

The group now has 320 approvals and has so far filed over 400 ANDAs

News
News | 31 July 2021

Sun Pharmaceutical Industries Q1FY22 consolidated PAT soars to Rs. 1408.65 Cr

It posted net loss of Rs.(2429.81) crores for the period ended June 30, 2020.

News
News | 31 July 2021

Zydus Wellness Q1FY22 consolidated net profit at Rs. 130.80 Cr

The company posted net profit of Rs.89.20 crores for the period ended June 30, 2020.

News
News | 30 July 2021

Eris Lifesciences planning new manufacturing facility

The new greenfield manufacturing facility will be operated alongside the Guwahati facility as a parallel unit thereby helping mitigate the risks of a single-location operation

News
News | 29 July 2021

RPG Life Sciences Q1FY22 PAT surges to Rs. 13.58 Cr

The company posted net profit of Rs.9.06 crores for the period ended June 30, 2020.

Startup

Digitization